as well as by the heart. Ethanol infusion, however, had no effect on glucose use by the diaphragm, lung, liver, skin, ileum, brain, and adipose tissue. The insulinstimulated glucose use was also inhibited by alcohol selectively in the muscles, with no effect on other tissues tested, except a moderate inhibition in the brain. Ethanol inhibited muscle glucose use by an average of ~50% under both basal and insulin-stimulated conditions. However, because insulin treatment more than doubled basal glucose use by these muscles, the 50% inhibition by ethanol treatment represents a greater inhibition of absolute glucose use under insulin-stimulated rather than under basal conditions.
Our data demonstrate that acute alcohol intake attenuates basal and hormoneinduced glucose utilization in a tissue-specific fashion. The inhibitory effect of alcohol on skeletal muscle glucose use could contribute to the previously observed decreased glucose recycling in humans after acute alcohol intake. euglycemic clamp; ethanol; rat; 2-deoxy-D-glucose; glucose transporter; SEVERAL STUDIES HAVE demonstrated that ethanol intake influences whole body and hepatic glucose metabolism (19) . Acute ethanol administration may cause moderate to severe hypoglycemia in fasting humans, rodents, or canines (10, 16, 31) . This ethanol effect has been attributed to inhibited gluconeogenesis caused by an elevated NADH-to-NAD+ ratio in hepatocytes metabolizing ethanol (14) . It was also shown that the attenuated hepatic gluconeogenesis was accompanied by a decreased peripheral glucose disappearance rate (25, 32) . Acute ethanol administration also attenuates the lipopolysaccharide (LPS)-induced elevated whole body glucose utilization (23). The mechanism responsible for the ethanol effects on glucose clearance or peripheral glucose utilization is not known. Because ethanol alters membrane fluidity (24), it is possible that the interaction of ethanol with membrane constituents, such as hormone receptors, may participate in the modulatory effects of ethanol on glucose homeostasis. Acute alcohol treatment was shown to cause insulin resistance, as determined in whole body glucose kinetics experiments (25, 33) . How ever, it is not known whether the attenuated glucose disappearance rate caused by ethanol is the consequence of a uniformly decreased glucose use by peripheral tissues or has specific organ targets.
In the present study, we aimed to elucidate the contribution of individual tissues to the attenuated glucose disappearance rate caused by ethanol in fasted rats. We tested the acute alcohol effects on basal and insulin-mediated glucose use by tissues employing the euglycemic hyperinsulinemic clamp technique. We used the 2-deoxy-D-glucose tracer method to determine the in vivo glucose utilization rates by individual tissues under these experimental conditions.
MATERIALS AND METHODS
Animal preparation. Male Sprague-Dawley rats (320-350 g body wt) were housed in a controlled environment with a 12:12-h light-dark cycle and were provided with standard rodent chow (Purina no. 5001; Purina Mills, St. Louis, MO) and water ad libitum. Before the experiment (1 h), rats were anesthetized with an intramuscular injection of ketamine (9 mg/lOO g body wt) and xylazine (0.9 mg/lOO body wt). Catheters (PE-50) were placed in the right and left jugular veins and left carotid artery using aseptic surgical techniques. The venous catheters were used for infusions and the arterial catheter to obtain blood samples for analysis. After the surgical procedure the rats were caged individually with no food but with water available ad libitum. After the overnight fast, the experiments were performed on conscious unrestrained rats with adherence to the National Institutes of Health guidelines for the use of experimental animals. Experimental protocol. The following four in vivo treatments formed our experimental groups: 1) saline infusion; 2) ethanol infusion; 3) euglycemic hyperinsulinemic clamp; and 4) ethanol infusion with euglycemic hyperinsulinemic clamp. Ethanol treatment was initiated with an injection of a priming dose of 0.87 ml/ 100 g body wt of 20% (vol/vol) ethanol followed by a continuous infusion of 20% ethanol at 0.15 ml l 100 g body wt-l-h-l (23). E ug ycemic 1 hyperinsulinemic clamp was performed as described earlier (15 Analyticprocedures. Phosphorylated metabolites of 2-deoxy-D-glucose were determined by the Somogyi method, as described in detail previously (22). The glucose utilization rate (R,) by different tissues was calculated from the integrated value of 2-deoxy-ti-glucose/glucose plasma specific activity, the intracellular accumulation of phosphorylated 2-deoxy-[ 14C]glucase, and the lump constant, which accounts for the discrimination between glucose and 2-deoxy-D-glucose (22). The lump constant (0.5) was determined experimentally as previously described (22).
Plasma insulin concentrations were determined by radioimmunoassay using porcine standards (Micromedic, Horsham, PA). Plasma lactate and blood alcohol concentrations were determined enzymatically from samples taken at 220 min of infusion (9,17).
Determination of GLUT-4 glucose transporter protein in muscles. After the in vivo treatments, muscle samples were taken and homogenized in aN-2-hydroxyethylpiperazine-iV'-2-ethanesulfonic acid buffer containing detergent and proteinase inhibitors as described in detail previously (13). The GLUT-4 content of muscle samples was determined by sodium dodecyl sulfate-polyacrylamide gel electrophoresis followed by Western blot analysis employing polyclonal antibodies against the COOH-terminal peptide of GLUT-4 (13). Data are presented as means t SE. Results for all variables were subjected to analysis of variance (ANOVA). When statistical analysis indicated nonhomogeneity of variance, ANOVA of ranks was substituted for values (7). Statistical differences were set at P < 0.05.
RESULTS
Under our experimental conditions, animals were euglycemic in all treatment groups (Table 1) . Insulin infusion resulted in plasma hormone levels of loo-130 pU/ml. The ethanol infusion employed in the study caused intoxicating blood levels of 180-190 mg/dl. Table 1 also shows that the glucose infusion rate that was required to maintain euglycemia was significantly lower during the combined ethanol and insulin treatments than during insulin infusion alone. It can be calculated from the glucose infusion rates throughout the experiments that an average of 0.76 g/kg body wt less glucose was required to maintain euglycemia in rats infused with insulin plus ethanol than after insulin treatment alone. The calculated total alcohol consumed by the animals during the experiments accounted for an average of 0.96 g/kg body wt.
Plasma lactate levels increased after ethanol or insulin infusion; however, the elevated lactate concentration Ethanol infusion alone markedly inhibited basal glucose use by skeletal muscles, including the white and red quadriceps, gastrocnemius, and soleus (Fig. 1) . As expected, skeletal muscle R, levels were significantly elevated after the eugycemic hyperinsulinemic clamp (Fig. 1 -clamp--clamp- (Fig. 3) . In the brain, ethanol infusion caused a moderate but statistically significant decrease of R, in hyperinsulinemit rats (Fig. 3) .
The marked inhibitory effects of ethanol on the basal or insulin-stimulated glucose use by muscles raised the question of whether these effects are mediated by alterations in the protein expression of the insulin-sensitive glucose transporter GLUT-4. Therefore, we determined the GLUT-4 glucose transporter contents of muscle tissues prepared from animals after the in vivo treatments. Figure 4 shows that, although the variability of fold alterations was high, insulin treatments tended to increase GLUT-4 content in skeletal muscles. Ethanol alone or in combination with insulin, however, did not cause consistent changes in GLUT-4 content in these muscles.
DISCUSSION
This study demonstrates that acute ethanol administration to overnight-fasted rats causes a marked and selective inhibition of glucose use by skeletal muscles. The attenuating effect of ethanol on glucose use by muscles is present under basal conditions as well as after insulin-stimulated glucose uptake. Skeletal muscle contributes -25-30% of the total peripheral glucose use in the body because of its large relative mass (8). Thus our findings may identify the site at which ethanol attenuates peripheral glucose utilization and causes insulin resistance demonstrated in previous studies (5, 25, 32, 33) .
The mechanism by which ethanol inhibits muscle glucose utilization is unknown. One possibility is that ethanol acts through its metabolite acetate. Acetate may be oxidized and/or incorporated into lipids of various tissues (18, 30) . Our data indicate that, in hyperinsulinemit rats, less glucose is required to maintain euglycemia in the presence of alcohol. The difference in the amount of glucose required to maintain euglycemia in tested. The inhibition caused by ethanol under basal or hyperinsulinemic conditions was similar, accounting for an -50% decrease. However, ethanol decreased the absolute rates of R, in the hyperinsulinemic rats more than in the controls. Figure 2 indicates that the macrophage-rich tissues (liver, lung, spleen, skin, and ileum) displayed marked insulin sensitivity, but ethanol administration had no effects on the R, by these tissues under basal or insulinstimulated conditions.
Ethanol infusion did not alter glucose use by fat or diaphragm either under basal or insulin-stimulated conditions (Fig. 3) . In the heart, basal glucose use was If acetate metabolism is a contributory factor in the effect of ethanol on muscle glucose use, one would expect differences between the alcohol effects in muscles containing a divergent population of fiber types. However, the response to ethanol was not different between the red portion of the quadriceps muscle, which has a relatively large percentage of fast-twitch red fibers, and the white quadriceps muscle, which predominantly is comprised of fast-twitch white fibers. Also, acetate infusion did not mimic the ethanol-induced insulin resistance in humans observed in whole body glucose kinetic experiments (32). These findings emphasize the importance of other mechanisms than acetate oxidation for the inhibitory effect of ethanol on muscle glucose use.
Alcohol, either directly or by its metabolites such as acetaldehyde, may affect hormone and cell interactions and/or interfere with cell functions. A well known effect of insulin action regulating cellular glucose use is the alteration of glucose transporter expression and/or translocation (6, 12, 20) . Our findings showed no significant ethanol effects on the total expression of GLUT-4 protein in any of the muscles tested. This, however, does not rule out the possibility that alcohol may influence membrane translocation of GLUT-4 protein. It was also shown that insulin causes a shift of GLUT-4 from the sarcoplasmic reticulum to the transverse tubules and terminal cisternae (11). Elucidation of the potential effects of alcohol on the translocation of GLUT-4 requires further detailed investigations on the distribution of transporters among different membrane components of skeletal muscles.
Alterations in blood flow can also modulate the overall rates of glucose use. Several studies demonstrated that muscle blood flow modulates insulin-mediated glucose uptake (1, 3). Furthermore, insulin was shown to elevate muscular blood flow (2). Therefore, it is possible that the blunted effect of insulin on muscle glucose use in alcohol-treated rats is related to decreased responsiveness of vascular beds in the tissue. Additional detailed studies are needed to elucidate these questions.
The ethanol effects on heart and diaphragm were different from those found in nonrespiratory skeletal muscles. Although ethanol caused marked inhibition of basal glucose use by the heart and tended to decrease basal glucose use by the diaphragm, it had no effect on these organs during hyperinsulinemic euglycemic clamp conditions. The finding that ethanol was not effective in inhibiting cardiac glucose use during the hyperinsulinemit euglycemic clamp in fasted animals suggests that the nutritional status of this organ primarily depends on noncarbohydrate catabolism (i.e., lactate and/or acetate) under these conditions. The explanation for the differences in response between these striated muscles is unknown; however, this finding suggests that the mechanism whereby ethanol interacts with glucose metabolism among muscles is not uniform. Furthermore, the mechanism of ethanol action can also be different under basal and insulin-stimulated conditions.
The fact that the inhibitory effect of ethanol on glucose use was restricted to skeletal muscles may raise the possibility that it is related to decreased muscle tone or voluntary motions of the animals under the influence of alcohol. The fact that alcohol inhibits absolute rates of glucose use more efficiently during insulin-stimulated than basal conditions, however, argues against this possibility and reinforces the suggestion that the mechanism of ethanol action may be different under these two metabolic conditions. Our previous studies indicated that immune competent cells in macrophage-rich tissues, such as in the liver, are important glucose consumers (21,271. Furthermore, LPS challenge markedly stimulated in vivo glucose use (211, which was accompanied by an elevated membrane content of conditions. This finding emphasizes again that the ethanol effect is not simply the consequence of altered metabolic balance but rather that alcohol or its metabolites might modulate regulatory mechanisms in a tissue-specific fashion. These data demonstrate that acute alcohol intake attenuates hormone-induced or basal glucose use by skeletal muscles, which could contribute to the previously observed decreased glucose disappearance rate after acute alcohol intake in humans and experimental animals (3 l-33).
The ethanol-induced insulin resistance can largely be dependent on the altered response of skeletal muscles, and it is not a uniform phenomenon involving most of the peripheral tissues. 
